{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:04:18Z","timestamp":1779332658181,"version":"3.51.4"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.drugalcdep.2012.03.026","type":"journal-article","created":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T12:46:34Z","timestamp":1335530794000},"page":"S33-S41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"S1","title":["Common and specific liability to addiction: Approaches to association studies of opioid addiction"],"prefix":"10.1016","volume":"123","author":[{"given":"David A.","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Jeanne","family":"Kreek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0005","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/sj.mp.4001455","article-title":"Glutamate receptor, ionotropic, N-methyl d-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit\/hyperactivity disorder in the 16p13 region","volume":"9","author":"Adams","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0010","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1172\/JCI21647","article-title":"Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression","volume":"114","author":"Alikhani-Koopaei","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0015","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0020","doi-asserted-by":"crossref","first-page":"11995","DOI":"10.1073\/pnas.90.24.11995","article-title":"Number of CpG islands and genes in human and mouse","volume":"90","author":"Antequera","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archpsyc.65.2.135","article-title":"An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study","volume":"65","author":"Anton","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.drugalcdep.2005.11.024","article-title":"Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis","volume":"83","author":"Arias","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0035","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/430454","article-title":"Candidate-gene screening and association analysis at the autism-susceptibility locus on chromosome 16p: evidence of association at GRIN2A and ABAT","volume":"76","author":"Barnby","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0040","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.mp.4001504","article-title":"Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden","volume":"9","author":"Bart","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0045","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300598","article-title":"Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden","volume":"30","author":"Bart","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0050","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.mp.4001768","article-title":"Association of galanin haplotypes with alcoholism and anxiety in two ethnically distinct populations","volume":"11","author":"Belfer","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ajhg.2008.11.011","article-title":"Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels","volume":"84","author":"Benyamin","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0060","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/sj.mp.4000331","article-title":"Mu opioid receptor gene variants: lack of association with alcohol dependence","volume":"2","author":"Bergen","year":"1997","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0065","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/hmg\/9.16.2395","article-title":"The DNA methyltransferases of mammals","volume":"9","author":"Bestor","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tips.2009.10.004","article-title":"Convergence of genetic findings for nicotine dependence and smoking related diseases with chromosome 15q24-25","volume":"31","author":"Bierut","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0075","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","article-title":"Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction","volume":"95","author":"Bond","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1101\/lm.777308","article-title":"Impaired discrimination learning in mice lacking the NMDA receptor NR2A subunit","volume":"15","author":"Brigman","year":"2008","journal-title":"Learn. Mem."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0085","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/457974b","article-title":"Molecular biology: the long and short of RNAs","volume":"457","author":"Carninci","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.molbrainres.2005.07.008","article-title":"Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males","volume":"140","author":"Cheng","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0095","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1126\/science.1162228","article-title":"Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters","volume":"322","author":"Core","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-1-60761-580-4_6","article-title":"Designs for linkage analysis and association studies of complex diseases","volume":"620","author":"Cui","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0105","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1471-4159.2009.06472.x","article-title":"Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction","volume":"112","author":"Deb","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0110","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/tpbi.2001.1542","article-title":"Genomic control, a new approach to genetic-based association studies","volume":"60","author":"Devlin","year":"2001","journal-title":"Theor. Popul. Biol."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbrc.2006.12.151","article-title":"DNA methylation and Sp1 binding determine the tissue-specific transcriptional activity of the mouse Abcc6 promoter","volume":"354","author":"Douet","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/embo-reports\/kvf053","article-title":"Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics","volume":"3","author":"Eberharter","year":"2002","journal-title":"EMBO Rep."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1359786806066041","article-title":"Using ancestry-informative markers to define populations and detect population stratification","volume":"20","author":"Enoch","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0130","series-title":"Structured Clinical Interview for DSM-IV Axis Disorders\u2014Patient Edition, SCID-I\/P, Version 2.0, 8\/98 revision","author":"First","year":"1998"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0022-2836(87)90689-9","article-title":"CpG islands in vertebrate genomes","volume":"196","author":"Gardiner-Garden","year":"1987","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ajmg.b.20111","article-title":"Association between low-activity serotonin transporter genotype and heroin dependence: behavioral and personality correlates","volume":"126B","author":"Gerra","year":"2004","journal-title":"Am. J. Med. Genet. B: Neuropsychiatr. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0145","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ajmg.b.30510","article-title":"Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction","volume":"144","author":"Gerra","year":"2007","journal-title":"Am. J. Med. Genet. B: Neuropsychiatr. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0150","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nrg2504","article-title":"Small silencing RNAs: an expanding universe","volume":"10","author":"Ghildiyal","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0155","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ajmg.b.30361","article-title":"Genome-wide linkage analysis of heroin dependence in Han Chinese: results from wave one of a multi-stage study","volume":"141B","author":"Glatt","year":"2006","journal-title":"Am. J. Med. Genet. B: Neuropsychiatr. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.drugalcdep.2007.02.022","article-title":"Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis","volume":"90","author":"Glatt","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0165","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0014-5793(98)01362-3","article-title":"Endomorphins fully activate a cloned human mu opioid receptor","volume":"439","author":"Gong","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0170","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1056\/NEJMra0808700","article-title":"Genomewide association studies and human disease","volume":"360","author":"Hardy","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0175","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.mp.4001695","article-title":"Genetic tests of biologic systems in affective disorders","volume":"10","author":"Hattori","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0180","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/alcalc\/agn032","article-title":"Addictions biology: haplotype-based analysis for 130 candidate genes on a single array","volume":"43","author":"Hodgkinson","year":"2008","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2009.08.004","article-title":"Potential association of DRD2 and DAT1 genetic variation with heroin dependence","volume":"464","author":"Hou","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00439-007-0453-9","article-title":"Significant association of DRD1 with nicotine dependence","volume":"123","author":"Huang","year":"2008","journal-title":"Hum. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00008571-200305000-00006","article-title":"A microsatellite repeat in the promoter of the N-methyl-d-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia","volume":"13","author":"Itokawa","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0200","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1126\/science.1138341","article-title":"RNA maps reveal new RNA classes and a possible function for pervasive transcription","volume":"316","author":"Kapranov","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0205","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1142\/S0219635207001635","article-title":"A118G polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin","volume":"6","author":"Kapur","year":"2007","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0376-8716(02)00308-3","article-title":"The Kreek\u2013McHugh\u2013Schluger\u2013Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications","volume":"69","author":"Kellogg","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0215","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1176\/appi.ajp.160.4.687","article-title":"Specificity of genetic and environmental risk factors for use and abuse\/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins","volume":"160","author":"Kendler","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0220","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0225","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1601-183X.2007.00341.x","article-title":"Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA","volume":"7","author":"Knafo","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0230","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature08625","article-title":"Parental origin of sequence variants associated with complex diseases","volume":"462","author":"Kong","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.57.1.1","article-title":"Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments","volume":"57","author":"Kreek","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0240","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1124\/mi.7.2.7","article-title":"Stress responsivity, addiction, and a functional variant of the human mu-opioid receptor gene","volume":"7","author":"Kreek","year":"2007","journal-title":"Mol. Interv."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0245","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nn1583","article-title":"Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction","volume":"8","author":"Kreek","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0250","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.coph.2008.12.016","article-title":"Opiate and cocaine addiction: from bench to clinic and back to the bench","volume":"9","author":"Kreek","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0255","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1471-4159.2007.04738.x","article-title":"The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor","volume":"103","author":"Kroslak","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0260","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuron.2005.09.023","article-title":"Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum","volume":"48","author":"Kumar","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0265","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/hmg\/ddm081","article-title":"Genomewide suggestive linkage of opioid dependence to chromosome 4q","volume":"16","author":"Lachman","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0270","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ajmg.b.30377","article-title":"Mutation screen of the GAD2 gene and association study of alcoholism in three populations","volume":"144","author":"Lappalainen","year":"2007","journal-title":"Am. J. Med. Genet. B: Neuropsychiatr. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0275","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1601-183X.2008.00410.x","article-title":"Genetic susceptibility to heroin addiction: a candidate gene association study","volume":"7","author":"Levran","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0280","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1601-183X.2009.00501.x","article-title":"Heroin addiction in African Americans: a hypothesis-driven association study","volume":"8","author":"Levran","year":"2009","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0285","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrg2536","article-title":"New insights into the genetics of addiction","volume":"10","author":"Li","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0290","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1530-0277.2006.00218.x","article-title":"Glutamate decarboxylase genes and alcoholism in Han Taiwanese men","volume":"30","author":"Loh","year":"2006","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0295","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/ajmg.b.30429","article-title":"Association analysis of GABA receptor subunit genes on 5q33 with heroin dependence in a Chinese male population","volume":"144","author":"Loh","year":"2007","journal-title":"Am. J. Med. Genet. B: Neuropsychiatr. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0300","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/hmg\/ddi244","article-title":"CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case\u2013control structured association study","volume":"14","author":"Luo","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0305","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1086\/504113","article-title":"Diplotype trend regression analysis of the ADH gene cluster and the ALDH2 gene: multiple significant associations with alcohol dependence","volume":"78","author":"Luo","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0310","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/hmg\/ddl460","article-title":"Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans","volume":"16","author":"Luo","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0315","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajmg.b.30589","article-title":"ADH7 variation modulates extraversion and conscientiousness in substance-dependent subjects","volume":"147B","author":"Luo","year":"2008","journal-title":"Am. J. Med. Genet. B: Neuropsychiatr. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0320","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0325","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1126\/science.1179438","article-title":"Essential role of the histone methyltransferase G9a in cocaine-induced plasticity","volume":"327","author":"Maze","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0330","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the addiction severity index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0335","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","article-title":"An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index","volume":"168","author":"McLellan","year":"1980","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0340","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrg2521","article-title":"Long non-coding RNAs: insights into functions","volume":"10","author":"Mercer","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0345","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/mp.2008.54","article-title":"Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans","volume":"14","author":"Meyer-Lindenberg","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0350","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1096\/fj.06-7118com","article-title":"Epigenetic regulation of human alpha1d-adrenergic receptor gene expression: a role for DNA methylation in Sp1-dependent regulation","volume":"21","author":"Michelotti","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0355","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/30764","article-title":"Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex","volume":"393","author":"Nan","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0360","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10519-007-9187-7","article-title":"TPH2 and TPH1: association of variants and interactions with heroin addiction","volume":"38","author":"Nielsen","year":"2008","journal-title":"Behav. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0365","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.mp.4002147","article-title":"Genotype patterns that contribute to increased risk for or protection from developing heroin addiction","volume":"13","author":"Nielsen","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0370","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/npp.2008.108","article-title":"Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts","volume":"34","author":"Nielsen","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2011.12.022","article-title":"Former heroin addicts with or without a history of cocaine dependence are more impulsive than controls","author":"Nielsen","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0380","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1074\/jbc.M807030200","article-title":"A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain","volume":"284","author":"Oertel","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0385","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/ajmg.b.30716","article-title":"Catechol-O-methyltransferase (COMT) gene variants: possible association of the Val158Met variant with opiate addiction in Hispanic women","volume":"147B","author":"Oosterhuis","year":"2008","journal-title":"Am. J. Med. Genet. B: Neuropsychiatr. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0390","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","article-title":"A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients","volume":"28","author":"Oslin","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0395","doi-asserted-by":"crossref","first-page":"e7969","DOI":"10.1371\/journal.pone.0007969","article-title":"How many genetic variants remain to be discovered?","volume":"4","author":"Pawitan","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0400","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1101\/gad.1428006","article-title":"The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis","volume":"20","author":"Pipes","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0405","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1126\/science.1164096","article-title":"RNA exosome depletion reveals transcription upstream of active human promoters","volume":"322","author":"Preker","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0410","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/genetics\/155.2.945","article-title":"Inference of population structure using multilocus genotype data","volume":"155","author":"Pritchard","year":"2000","journal-title":"Genetics"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0415","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neulet.2008.02.042","article-title":"Association of polymorphisms in the melanocortin receptor type 2 (MC2R, ACTH receptor) gene with heroin addiction","volume":"435","author":"Proudnikov","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0420","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.fpc.0000182782.87932.d6","article-title":"Association analysis of polymorphisms in serotonin 1B receptor (HTR1B) gene with heroin addiction: a comparison of molecular and statistically estimated haplotypes","volume":"16","author":"Proudnikov","year":"2006","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0425","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1176\/appi.ajp.2008.08091354","article-title":"Genomewide association studies: history, rationale, and prospects for psychiatric disorders","volume":"166","author":"Psychiatric GWAS Consortium Coordinating Committee","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0430","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.neuron.2007.09.032","article-title":"Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli","volume":"56","author":"Renthal","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0435","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/35049533","article-title":"DNA methylation in health and disease","volume":"1","author":"Robertson","year":"2000","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0440","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1126\/science.1162253","article-title":"Divergent transcription from active promoters","volume":"322","author":"Seila","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0445","doi-asserted-by":"crossref","first-page":"e5225","DOI":"10.1371\/journal.pone.0005225","article-title":"Supplementing high-density SNP microarrays for additional coverage of disease-related genes: addiction as a paradigm","volume":"4","author":"Saccone","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0450","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/ng.481","article-title":"A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes","volume":"41","author":"Shinawi","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0455","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature07229","article-title":"Large recurrent microdeletions associated with schizophrenia","volume":"455","author":"Stefansson","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0460","first-page":"28","article-title":"Combined effect of promoter polymorphisms in the dopamine D4 receptor and the serotonin transporter genes in heroin dependence","volume":"7","author":"Szilagyi","year":"2005","journal-title":"Neuropsychopharmacol. Hung."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0465","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neulet.2006.09.022","article-title":"Significant linkage and association between a functional (GT)n polymorphism in promoter of the N-methyl-d-aspartate receptor subunit gene (GRIN2A) and schizophrenia","volume":"409","author":"Tang","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0470","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jpsychires.2006.06.001","article-title":"Association of a Met88Val diazepam binding inhibitor (DBI) gene polymorphism and anxiety disorders with panic attacks","volume":"41","author":"Thoeringer","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0475","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1126\/science.1146554","article-title":"Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma","volume":"317","author":"Thorleifsson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0480","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nature06846","article-title":"A variant associated with nicotine dependence, lung cancer and peripheral arterial disease","volume":"452","author":"Thorgeirsson","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0485","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/(SICI)1096-8628(19960920)67:5<473::AID-AJMG6>3.0.CO;2-L","article-title":"Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs","volume":"67","author":"Tsuang","year":"1996","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0490","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/archpsyc.55.11.967","article-title":"Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities","volume":"55","author":"Tsuang","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0495","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.mp.4001387","article-title":"Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD","volume":"9","author":"Turic","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0500","first-page":"629","article-title":"The relationship between alcoholism and DBI gene polymorphism in Japanese\u2013genotyping of the +529A\/T in DBI gene polymorphism based on PCR","volume":"42","author":"Waga","year":"2007","journal-title":"Nihon Arukoru Yakubutsu Igakkai Zasshi"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0505","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/hmg\/ddh194","article-title":"Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome","volume":"13","author":"Wang","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0510","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/sj.mp.4001503","article-title":"Examination of AVPR1a as an autism susceptibility gene","volume":"9","author":"Wassink","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0515","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","author":"Wellcome Trust Case Control Consortium","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0520","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archpsyc.61.6.597","article-title":"Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations","volume":"61","author":"Xu","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0525","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/ajmg.b.30531","article-title":"The opioid system in alcohol and drug dependence: family-based association study","volume":"144","author":"Xuei","year":"2007","journal-title":"Am. J. Med. Genet. B: Neuropsychiatr. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0530","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00439-008-0501-0","article-title":"Substance dependence low-density whole genome association study in two distinct American populations","volume":"123","author":"Yu","year":"2008","journal-title":"Hum. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0535","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00008571-200412000-00002","article-title":"Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction","volume":"14","author":"Yuferov","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0540","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.biopsych.2006.07.012","article-title":"Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population","volume":"61","author":"Zhang","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0545","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.genom.9.081307.164217","article-title":"Copy number variation in human health, disease, and evolution","volume":"10","author":"Zhang","year":"2009","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0550","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.mp.4002035","article-title":"The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk","volume":"13","author":"Zhang","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0555","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/hmg\/ddl024","article-title":"Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence","volume":"15","author":"Zhang","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0560","doi-asserted-by":"crossref","first-page":"32618","DOI":"10.1074\/jbc.M504942200","article-title":"Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G","volume":"280","author":"Zhang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drugalcdep.2012.03.026_bib0565","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1601-183X.2007.00314.x","article-title":"Association of the 54-nucleotide repeat polymorphism of hPer3 with heroin dependence in Han Chinese population","volume":"7","author":"Zou","year":"2008","journal-title":"Genes Brain Behav."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612001159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612001159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:52:46Z","timestamp":1759827166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871612001159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":113,"alternative-id":["S0376871612001159"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.03.026","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Common and specific liability to addiction: Approaches to association studies of opioid addiction","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}